KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in TaxesDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Gsk (GSK) over the last 17 years, with Q4 2025 value amounting to -$1.2 billion.

  • Gsk's Cash from Investing Activities fell 25568.85% to -$1.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$5.6 billion, marking a year-over-year decrease of 98563.22%. This contributed to the annual value of -$5.6 billion for FY2025, which is 25532.71% down from last year.
  • According to the latest figures from Q4 2025, Gsk's Cash from Investing Activities is -$1.2 billion, which was down 25568.85% from -$2.1 billion recorded in Q3 2025.
  • In the past 5 years, Gsk's Cash from Investing Activities registered a high of $971.9 million during Q2 2024, and its lowest value of -$4.9 billion during Q4 2022.
  • For the 5-year period, Gsk's Cash from Investing Activities averaged around -$1.3 billion, with its median value being -$891.8 million (2024).
  • As far as peak fluctuations go, Gsk's Cash from Investing Activities crashed by 718410.15% in 2022, and later surged by 18056.86% in 2024.
  • Over the past 5 years, Gsk's Cash from Investing Activities (Quarter) stood at -$314.1 million in 2021, then plummeted by 1445.3% to -$4.9 billion in 2022, then surged by 64.92% to -$1.7 billion in 2023, then soared by 146.81% to $797.1 million in 2024, then plummeted by 255.69% to -$1.2 billion in 2025.
  • Its last three reported values are -$1.2 billion in Q4 2025, -$2.1 billion for Q3 2025, and -$833.8 million during Q2 2025.